PubMed:1840295
Annnotations
Glycan-Motif
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 294-301 | https://glytoucan.org/Structures/Glycans/G70323CJ | denotes | mannose |
T2 | 663-670 | https://glytoucan.org/Structures/Glycans/G70323CJ | denotes | mannose |
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 294-301 | Glycan_Motif | denotes | mannose | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G70323CJ |
T2 | 663-670 | Glycan_Motif | denotes | mannose | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G70323CJ |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 294-301 | https://glytoucan.org/Structures/Glycans/G70323CJ | denotes | mannose |
T2 | 663-670 | https://glytoucan.org/Structures/Glycans/G70323CJ | denotes | mannose |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-146 | Sentence | denotes | Oligosaccharides at each glycosylation site make structure-dependent contributions to biological properties of human tissue plasminogen activator. |
TextSentencer_T2 | 147-274 | Sentence | denotes | The effect of altering oligosaccharide structures at sites 184 and 448 of tissue plasminogen activator (tPA) has been examined. |
TextSentencer_T3 | 275-414 | Sentence | denotes | Alteration to high-mannose forms at sites 184 and 448 was accomplished by the growth of cells in the presence of deoxymannojirimycin (dMM). |
TextSentencer_T4 | 415-545 | Sentence | denotes | Modification to neutral, unsialylated forms at these sites was achieved by neuraminidase treatment of control preparations of tPA. |
TextSentencer_T5 | 546-716 | Sentence | denotes | Oligosaccharides at site 117 were not markedly affected by either treatment because structures at this site are high-mannose and not sialylated in untreated preparations. |
TextSentencer_T6 | 717-901 | Sentence | denotes | The effect on enzymatic activity and on a related property, lysine affinity, was determined. dMM treatment was found to increase both the lysine affinity and catalytic activity of tPA. |
TextSentencer_T7 | 902-999 | Sentence | denotes | Neuraminidase treatment increased enzyme activity, but was without effect on affinity for lysine. |
TextSentencer_T8 | 1000-1162 | Sentence | denotes | To evaluate the effects of alterations at site 184 and site 448, the catalytic activity and lysine affinity of type I and type II tPA were monitored individually. |
TextSentencer_T9 | 1163-1482 | Sentence | denotes | In the dMM-treated sample, type I tPA (with sugars at sites 117, 184 and 448) was found to have 2- to 3-fold increased catalytic activity and an affinity for lysine which was greater than that of type I from untreated preparations, but less than that of control type II tPA (containing sugar only at sites 117 and 448). |
TextSentencer_T10 | 1483-1592 | Sentence | denotes | In neuraminidase-treated type I, catalytic activity was also enhanced but lysine affinity remained unchanged. |
TextSentencer_T11 | 1593-1822 | Sentence | denotes | Type II from dMM- and neuraminidase-treated preparations had catalytic activity that was increased approximately 1.5-fold compared to untreated controls, whereas affinity for lysine was unchanged.(ABSTRACT TRUNCATED AT 250 WORDS) |
T1 | 0-146 | Sentence | denotes | Oligosaccharides at each glycosylation site make structure-dependent contributions to biological properties of human tissue plasminogen activator. |
T2 | 147-274 | Sentence | denotes | The effect of altering oligosaccharide structures at sites 184 and 448 of tissue plasminogen activator (tPA) has been examined. |
T3 | 275-414 | Sentence | denotes | Alteration to high-mannose forms at sites 184 and 448 was accomplished by the growth of cells in the presence of deoxymannojirimycin (dMM). |
T4 | 415-545 | Sentence | denotes | Modification to neutral, unsialylated forms at these sites was achieved by neuraminidase treatment of control preparations of tPA. |
T5 | 546-716 | Sentence | denotes | Oligosaccharides at site 117 were not markedly affected by either treatment because structures at this site are high-mannose and not sialylated in untreated preparations. |
T6 | 717-901 | Sentence | denotes | The effect on enzymatic activity and on a related property, lysine affinity, was determined. dMM treatment was found to increase both the lysine affinity and catalytic activity of tPA. |
T7 | 902-999 | Sentence | denotes | Neuraminidase treatment increased enzyme activity, but was without effect on affinity for lysine. |
T8 | 1000-1162 | Sentence | denotes | To evaluate the effects of alterations at site 184 and site 448, the catalytic activity and lysine affinity of type I and type II tPA were monitored individually. |
T9 | 1163-1482 | Sentence | denotes | In the dMM-treated sample, type I tPA (with sugars at sites 117, 184 and 448) was found to have 2- to 3-fold increased catalytic activity and an affinity for lysine which was greater than that of type I from untreated preparations, but less than that of control type II tPA (containing sugar only at sites 117 and 448). |
T10 | 1483-1592 | Sentence | denotes | In neuraminidase-treated type I, catalytic activity was also enhanced but lysine affinity remained unchanged. |
T11 | 1593-1822 | Sentence | denotes | Type II from dMM- and neuraminidase-treated preparations had catalytic activity that was increased approximately 1.5-fold compared to untreated controls, whereas affinity for lysine was unchanged.(ABSTRACT TRUNCATED AT 250 WORDS) |
T1 | 0-146 | Sentence | denotes | Oligosaccharides at each glycosylation site make structure-dependent contributions to biological properties of human tissue plasminogen activator. |
T2 | 147-274 | Sentence | denotes | The effect of altering oligosaccharide structures at sites 184 and 448 of tissue plasminogen activator (tPA) has been examined. |
T3 | 275-414 | Sentence | denotes | Alteration to high-mannose forms at sites 184 and 448 was accomplished by the growth of cells in the presence of deoxymannojirimycin (dMM). |
T4 | 415-545 | Sentence | denotes | Modification to neutral, unsialylated forms at these sites was achieved by neuraminidase treatment of control preparations of tPA. |
T5 | 546-716 | Sentence | denotes | Oligosaccharides at site 117 were not markedly affected by either treatment because structures at this site are high-mannose and not sialylated in untreated preparations. |
T6 | 717-901 | Sentence | denotes | The effect on enzymatic activity and on a related property, lysine affinity, was determined. dMM treatment was found to increase both the lysine affinity and catalytic activity of tPA. |
T7 | 902-999 | Sentence | denotes | Neuraminidase treatment increased enzyme activity, but was without effect on affinity for lysine. |
T8 | 1000-1162 | Sentence | denotes | To evaluate the effects of alterations at site 184 and site 448, the catalytic activity and lysine affinity of type I and type II tPA were monitored individually. |
T9 | 1163-1482 | Sentence | denotes | In the dMM-treated sample, type I tPA (with sugars at sites 117, 184 and 448) was found to have 2- to 3-fold increased catalytic activity and an affinity for lysine which was greater than that of type I from untreated preparations, but less than that of control type II tPA (containing sugar only at sites 117 and 448). |
T10 | 1483-1592 | Sentence | denotes | In neuraminidase-treated type I, catalytic activity was also enhanced but lysine affinity remained unchanged. |
T11 | 1593-1822 | Sentence | denotes | Type II from dMM- and neuraminidase-treated preparations had catalytic activity that was increased approximately 1.5-fold compared to untreated controls, whereas affinity for lysine was unchanged.(ABSTRACT TRUNCATED AT 250 WORDS) |
GlycoBiology-FMA
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
_T1 | 0-16 | FMAID:82742 | denotes | Oligosaccharides |
_T2 | 0-16 | FMAID:196731 | denotes | Oligosaccharides |
_T3 | 117-123 | FMAID:256050 | denotes | tissue |
_T4 | 170-185 | FMAID:196731 | denotes | oligosaccharide |
_T5 | 170-185 | FMAID:82742 | denotes | oligosaccharide |
_T6 | 221-227 | FMAID:256050 | denotes | tissue |
_T7 | 294-301 | FMAID:82801 | denotes | mannose |
_T8 | 294-301 | FMAID:196796 | denotes | mannose |
_T9 | 363-368 | FMAID:68646 | denotes | cells |
_T10 | 363-368 | FMAID:169002 | denotes | cells |
_T11 | 546-562 | FMAID:82742 | denotes | Oligosaccharides |
_T12 | 546-562 | FMAID:196731 | denotes | Oligosaccharides |
_T13 | 663-670 | FMAID:196796 | denotes | mannose |
_T14 | 663-670 | FMAID:82801 | denotes | mannose |
_T15 | 777-783 | FMAID:196747 | denotes | lysine |
_T16 | 777-783 | FMAID:82758 | denotes | lysine |
_T17 | 855-861 | FMAID:82758 | denotes | lysine |
_T18 | 855-861 | FMAID:196747 | denotes | lysine |
_T19 | 992-998 | FMAID:196747 | denotes | lysine |
_T20 | 992-998 | FMAID:82758 | denotes | lysine |
_T21 | 1092-1098 | FMAID:196747 | denotes | lysine |
_T22 | 1092-1098 | FMAID:82758 | denotes | lysine |
_T23 | 1207-1213 | FMAID:196724 | denotes | sugars |
_T24 | 1321-1327 | FMAID:82758 | denotes | lysine |
_T25 | 1321-1327 | FMAID:196747 | denotes | lysine |
_T26 | 1449-1454 | FMAID:196724 | denotes | sugar |
_T27 | 1557-1563 | FMAID:82758 | denotes | lysine |
_T28 | 1557-1563 | FMAID:196747 | denotes | lysine |
_T29 | 1768-1774 | FMAID:196747 | denotes | lysine |
_T30 | 1768-1774 | FMAID:82758 | denotes | lysine |
uniprot-human
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 124-135 | http://www.uniprot.org/uniprot/P00747 | denotes | plasminogen |
T2 | 228-239 | http://www.uniprot.org/uniprot/P00747 | denotes | plasminogen |
T3 | 251-254 | http://www.uniprot.org/uniprot/Q9BU99 | denotes | tPA |
T4 | 541-544 | http://www.uniprot.org/uniprot/Q9BU99 | denotes | tPA |
T5 | 897-900 | http://www.uniprot.org/uniprot/Q9BU99 | denotes | tPA |
T6 | 1130-1133 | http://www.uniprot.org/uniprot/Q9BU99 | denotes | tPA |
T7 | 1197-1200 | http://www.uniprot.org/uniprot/Q9BU99 | denotes | tPA |
T8 | 1433-1436 | http://www.uniprot.org/uniprot/Q9BU99 | denotes | tPA |
uniprot-mouse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 124-135 | http://www.uniprot.org/uniprot/P20918 | denotes | plasminogen |
T2 | 228-239 | http://www.uniprot.org/uniprot/P20918 | denotes | plasminogen |
T3 | 251-254 | http://www.uniprot.org/uniprot/P11214 | denotes | tPA |
T4 | 541-544 | http://www.uniprot.org/uniprot/P11214 | denotes | tPA |
T5 | 897-900 | http://www.uniprot.org/uniprot/P11214 | denotes | tPA |
T6 | 1130-1133 | http://www.uniprot.org/uniprot/P11214 | denotes | tPA |
T7 | 1197-1200 | http://www.uniprot.org/uniprot/P11214 | denotes | tPA |
T8 | 1433-1436 | http://www.uniprot.org/uniprot/P11214 | denotes | tPA |
T9 | 1809-1811 | http://www.uniprot.org/uniprot/Q8VHK8 | denotes | AT |
GlycoBiology-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 117-123 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissue |
T2 | 221-227 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissue |
T3 | 363-368 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T4 | 759-766 | http://purl.bioontology.org/ontology/NCBITAXON/353209 | denotes | related |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 25-38 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
T2 | 124-145 | http://purl.obolibrary.org/obo/GO_0031639 | denotes | plasminogen activator |
T3 | 228-249 | http://purl.obolibrary.org/obo/GO_0031639 | denotes | plasminogen activator |
T4 | 251-254 | http://purl.obolibrary.org/obo/GO_0031299 | denotes | tPA |
T5 | 541-544 | http://purl.obolibrary.org/obo/GO_0031299 | denotes | tPA |
T6 | 897-900 | http://purl.obolibrary.org/obo/GO_0031299 | denotes | tPA |
T7 | 1130-1133 | http://purl.obolibrary.org/obo/GO_0031299 | denotes | tPA |
T8 | 1197-1200 | http://purl.obolibrary.org/obo/GO_0031299 | denotes | tPA |
T9 | 1433-1436 | http://purl.obolibrary.org/obo/GO_0031299 | denotes | tPA |
T10 | 353-359 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
T11 | 353-368 | http://purl.obolibrary.org/obo/GO_0016049 | denotes | growth of cells |
T12 | 679-689 | http://purl.obolibrary.org/obo/GO_0097503 | denotes | sialylated |
T13 | 875-893 | http://purl.obolibrary.org/obo/GO_0003824 | denotes | catalytic activity |
T14 | 1069-1087 | http://purl.obolibrary.org/obo/GO_0003824 | denotes | catalytic activity |
T15 | 1282-1300 | http://purl.obolibrary.org/obo/GO_0003824 | denotes | catalytic activity |
T16 | 1516-1534 | http://purl.obolibrary.org/obo/GO_0003824 | denotes | catalytic activity |
T17 | 1654-1672 | http://purl.obolibrary.org/obo/GO_0003824 | denotes | catalytic activity |
T18 | 936-951 | http://purl.obolibrary.org/obo/GO_0003824 | denotes | enzyme activity |
T19 | 1079-1098 | http://purl.obolibrary.org/obo/GO_0019835 | denotes | activity and lysine |
GO-CC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 363-368 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
UBERON-AE
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 117-123 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
T2 | 221-227 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
EDAM-topics
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 111-116 | http://edamontology.org/topic_2815 | denotes | human |
T2 | 1182-1188 | http://edamontology.org/topic_3277 | denotes | sample |
EDAM-DFO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 49-58 | http://edamontology.org/data_0883 | denotes | structure |
T2 | 186-196 | http://edamontology.org/data_0883 | denotes | structures |
T3 | 630-640 | http://edamontology.org/data_0883 | denotes | structures |
T4 | 1790-1798 | http://edamontology.org/data_2849 | denotes | ABSTRACT |
GlycoBiology-Motifs
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 289-301 | http://rdf.glycoinfo.org/glycan/G00028MO | denotes | high-mannose |
T2 | 658-670 | http://rdf.glycoinfo.org/glycan/G00028MO | denotes | high-mannose |
GlyTouCan-IUPAC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
GlycanIUPAC_T1 | 1207-1213 | "http://rdf.glycoinfo.org/glycan/G59665TO" | denotes | sugars |
GlycanIUPAC_T2 | 1449-1454 | "http://rdf.glycoinfo.org/glycan/G59665TO" | denotes | sugar |
GlycanIUPAC_T3 | 1207-1213 | "http://rdf.glycoinfo.org/glycan/G32915EI" | denotes | sugars |
GlycanIUPAC_T4 | 1449-1454 | "http://rdf.glycoinfo.org/glycan/G32915EI" | denotes | sugar |
GlycanIUPAC_T5 | 1207-1213 | "http://rdf.glycoinfo.org/glycan/G60625TS" | denotes | sugars |
GlycanIUPAC_T6 | 1449-1454 | "http://rdf.glycoinfo.org/glycan/G60625TS" | denotes | sugar |
performance-test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-UBERON-AE-B_T1 | 117-123 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
PD-UBERON-AE-B_T2 | 221-227 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 111-116 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 117-123 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
T2 | 221-227 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
CL-cell
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 1111-1117 | Cell | denotes | type I | http://purl.obolibrary.org/obo/CL:0004120|http://purl.obolibrary.org/obo/CL:0004138 |
T3 | 1190-1196 | Cell | denotes | type I | http://purl.obolibrary.org/obo/CL:0004120|http://purl.obolibrary.org/obo/CL:0004138 |
T5 | 1359-1365 | Cell | denotes | type I | http://purl.obolibrary.org/obo/CL:0004120|http://purl.obolibrary.org/obo/CL:0004138 |
T7 | 1508-1514 | Cell | denotes | type I | http://purl.obolibrary.org/obo/CL:0004120|http://purl.obolibrary.org/obo/CL:0004138 |